What Can China Teach Us About CAR T is the final installment of our CAR-T series and discusses how China has embraced CAR-T therapy. Our panelists also touch on how China and the US can grow off of each other’s strengths.
- Bill Farley, VP of Business and Corporate Development, Sorrento Therapeutics
- Anil Goyal, Chief Business Officer, MimiVax
- Michael Catelani, Chief Operating and Financial Officer, Anixa Biosciences
Find parts 1 and 2 below:
Subscribe to Kineticos to receive weekly emails containing insightful content.